Comprehensive Review on Rheumatoid Arthritis
DOI:
https://doi.org/10.22270/ijmspr.v8i3.58Keywords:
Rheumatoid arthritis, Pathogenesis, Disease modifying anti-arthritic drugs, Genetics, Environmental, AutoantibodiesAbstract
Rheumatoid arthritis (RA) is a chronic inflammatory, systemic, progressive, autoimmune disease in which the body’s immune system whose major role is to protect the health by attacking foreign bacteria and viruses are mistakenly, attacking the joints resulting in thickened synovium, pannus formation & destruction of bone, cartilage. Many complications can follow such as permanent joint damage requiring arthroplasty, rheumatoid vasculitis and elty’s syndrome requiring splenectomy if it remains unaddressed. Still now researchers are unable to know the exact cause of this disease. However, it is believed that age, gender, genetics and environmental exposure (cigarette smoking, air pollutants and occupational) play a role in development of RA. As there is no cure for RA, the treatment goals are to reduce the pain and stop/slow the further damage. The identification of novel autoantibodies has improved diagnostic accuracy, and newly developed classification criteria facilitate the recognition and study of the disease early in its course. New clinical assessment tools are able to better characterize disease activity states, which are correlated with progression of damage and disability and permit improved follow up. In addition, better understanding of the pathogenesis of RA through recognition of key cells and cytokines has led to the development of targeted disease-modifying antirheumatic drugs. Altogether, the improved understanding of the pathogenetic processes involved, rational use of established drugs and development of new drugs and reliable assessment tools have drastically altered the lives of individuals with RA over the past 2 decades. In this review, we discuss the epidemiology, pathophysiology, diagnosis and management of RA.
Keywords: Rheumatoid arthritis, Pathogenesis, Disease modifying anti-arthritic drugs, Genetics, Environmental, Autoantibodies
References
Swain SS, Bhuyan N, Meher CP. A Short review on rheumatoid arthritis (RA); PharmaTutor; 2016; 4(5); 35-40.
Lee J-E, Kim IJ, Cho M-S, Lee J. A Case of rheumatoid vasculitis involving hepatic artery in early rheumatoid arthritis. J Korean Med Sci. 2017; 32:1207-1210. https://doi.org/10.3346/jkms.2017.32.7.1207
Fox CQ, Ahmed SS. Physician assistant's clinical review cards. Philadelphia, F. A. Davis Company, 2002; 138-139.
McInnes IB, Schett G. The Pathogenesis of rheumatoid arthritis. N Engl J Med. 2011; 365:2205-2219. https://doi.org/10.1056/NEJMra1004965
Chaudhari K, Rizvi S, Syed BA. Rheumatoid arthritis: current and future trends. Nat Rev Drug Discov. 2016; 15:305-306. https://doi.org/10.1038/nrd.2016.21
Picerno V, Ferro F, Adinolfi A, Valentini E, Tani C, Alunno A. One year in review: the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2015; 33:551-558.
Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 2006; 36:182-188. https://doi.org/10.1016/j.semarthrit.2006.08.006
Chopra A, Abdel-Nasser A. Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract Res Clin Rheumatol. 2008; 22:583-604. https://doi.org/10.1016/j.berh.2008.07.001
McGonagle D, Hermann KG, Tan AL. Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era. Rheumatology (Oxford). 2015; 54:29-38. https://doi.org/10.1093/rheumatology/keu328
Piyarulli D, Koolaee RM. 22-Year-Old Female with Joint Pain. In Piyarulli D, Koolaee RM, editors. Medicine Morning Report: Beyond the Pearls. Philadelphia, Elsevier, 2016; 65-77.
Staheli LT. Lower extremity management. In: Staheli LT, Hall JG, Jaffe KM, Paholke DO, editors. Arthrogryposis: A Text Atlas. Cambridge, Cambridge University Press, 1998; 55-73.
Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, Kavanaugh A, McInnes IB, Solomon DH, Strand V, Yamamoto K. Rheumatoid arthritis. Nature reviews. Dis Primers. 2018; 4:418001. https://doi.org/10.1038/nrdp.2018.1
U.S. National Library of Medicine. Rheumatoid arthritis. https://medlineplus.gov/rheumatoidarthritis.html.
U.S. Department of Health & Human Services. Rheumatoid arthritis. https://report.nih.gov/nihfactsheets/ViewFactSheet.aspx?csid=63.
Patel NS, Jain DK, Nagar H, Patel A, Chandel HS. Evaluation of analgesic and antipyretic activity of Tridax procumbens leaves extract. RGUHS J Pharm Sci. 2011; 1(3):226-31. https://doi.org/10.5530/rjps.2011.3.9
Minichiello E, Semerano L, Boissier MC. Time trends in the incidence, prevalence, and severity of rheumatoid arthritis: a systematic literature review. Joint Bone Spine.2016; 83(6):625-630. https://doi.org/10.1016/j.jbspin.2016.07.007
Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016; 388(10055):2023-2038. https://doi.org/10.1016/S0140-6736(16)30173-8
Derksen VFAM, Huizinga TWJ, van der Woude D. The role of autoantibodies in thepathophysiology of rheumatoid arthritis. Semin Immunopathol. 2017; 39(4):437-446. https://doi.org/10.1007/s00281-017-0627-z
Wegner N, Lundberg K, Kinloch A, Fisher B, Malmström V, Feldmann M, Venables PJ.Autoimmunity to specific citrullinated proteins gives the first clues to the etiology ofrheumatoid arthritis. Immunol Rev. 2010; 233(1):34-54. https://doi.org/10.1111/j.0105-2896.2009.00850.x
López-Mejías R, Carmona FD, Genre F, Remuzgo-Martínez S, González-Juanatey C, et al., Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness inRheumatoid Arthritis: A Genome-Wide Association Study. Arthritis Rheumatol. 2019; 71(3):351-360. https://doi.org/10.1002/art.40734
Makrygiannakis D, Hermansson M, Ulfgren AK, Nicholas AP, Zendman AJ, Eklund A,Grunewald J, Skold CM, Klareskog L, Catrina AI. Smoking increases peptidylargininedeiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells.Ann Rheum Dis. 2008; 67(10):1488-92. https://doi.org/10.1136/ard.2007.075192
De Hair MJ, van de Sande MG, Ramwadhdoebe TH, Hansson M, Landewé R, et al., Features of the synovium of individuals at risk of developing rheumatoid arthritis:implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol. 2014; 66(3):513-22. https://doi.org/10.1002/art.38273
Lally F, Smith E, Filer A, Stone MA, Shaw JS, Nash GB, Buckley CD, Rainger GE. Anovel mechanism of neutrophil recruitment in a coculture model of the rheumatoidsynovium. Arthritis Rheum. 2005; 52(11):3460-9. https://doi.org/10.1002/art.21394
Demasi M, Cleland LG, Cook-Johnson RJ, James MJ. Effects of hypoxia on the expressionand activity of cyclooxygenase 2 in fibroblast-like synoviocytes: interactions withmonocyte-derived soluble mediators. Arthritis Rheum. 2004; 50(8):2441-9. https://doi.org/10.1002/art.20429
Chua-Aguilera CJ, Möller B, Yawalkar N. Skin Manifestations of Rheumatoid Arthritis,Juvenile Idiopathic Arthritis, and Spondyloarthritides. Clin Rev Allergy Immunol. 2017; 53(3):371-393. https://doi.org/10.1007/s12016-017-8632-5
Kortekangas P, Aro HT, Tuominen J, Toivanen A. Synovial fluid leukocytosis in bacterialarthritis vs. reactive arthritis and rheumatoid arthritis in the adult knee. Scand J Rheumatol.1992; 21(6):283-8. https://doi.org/10.3109/03009749209099243
Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T. Evidence of significant radiographicdamage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol. 1989; 16(5):585-91.
McQueen FM. The use of MRI in early RA. Rheumatology (Oxford). 2008; 47(11):1597-9. https://doi.org/10.1093/rheumatology/ken332
McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, McLean L. Magneticresonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosionsdespite clinical improvement. Ann Rheum Dis. 1999; 58(3):156-63. https://doi.org/10.1136/ard.58.3.156
Gupta S, Jain DK, Raghuwanshi MB, Khan MA, Chandel HS, Pathak AK. Wound healing activity of polyherbal formulation on excision based wound model in mice. Plant Archives. 2008; 8(2):783-5.
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, et al., 2010Rheumatoid arthritis classification criteria: an American College ofRheumatology/European League Against Rheumatism collaborative initiative. ArthritisRheum. 2010; 62(9):2569-81. https://doi.org/10.1002/art.27584
Ong CKS, Lirk P, Tan CH, Seymour RA. An Evidence-Based Update on Nonsteroidal Anti- Inflammatory Drugs. Clin Med Res 2007; 5:19-34. https://doi.org/10.3121/cmr.2007.698
Combe B, Landewe R, Daien CI, et al. 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis 2017; 76:948-959. https://doi.org/10.1136/annrheumdis-2016-210602
Liu D, Ahmet A, Ward L, Krishnamoorthy P, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 2013; 9:30. https://doi.org/10.1186/1710-1492-9-30
Whittle SL, Colebatch AN, Buchbinder R, et al. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology (Oxford) 2012; 51:1416-1425. https://doi.org/10.1093/rheumatology/kes032
Richards BL, Whittle SL, van der Heijde DM, et al. The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl 2012; 90:21-27. https://doi.org/10.3899/jrheum.120338
Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010; 69:964-75. https://doi.org/10.1136/ard.2009.126532
Tian H, Cronstein BN. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. Bull NYU Hosp Jt Dis 2007; 65:168-73.
Daien CI, Hua C, Combe B, et al. Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis. RMD Open 2017; 3:e000404. https://doi.org/10.1136/rmdopen-2016-000404
Khatri S, Dhanoriya C, Jain DK. Zika virus (ZIKV) disease: past, present and future. Journal of Drug Delivery and Therapeutics. 2018; 8(6-s):320-7. https://doi.org/10.22270/jddt.v8i6-s.2076
Volin MV, Harlow LA, Woods JM, et al. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis. Arthritis Rheum 1999; 42:1927-1935. https://doi.org/10.1002/1529-0131(199909)42:9<1927::AID-ANR19>3.0.CO;2-X
Sailaja AK. An overall review on rheumatoid arthritis. Journal of Current Pharma Research 2014; 4:1138-1143. https://doi.org/10.33786/JCPR.2014.v04i02.005
Kumar P, Banik S. Pharmacotherapy Options in Rheumatoid Arthritis. Clin Med Insights Arthritis Musculoskelet Disord 2013; 6:35-43. https://doi.org/10.4137/CMAMD.S5558
Bullock J, Rizvi SA, Saleh AM, Ahmed SS, Do DP, Ansari RA, Ahmed J. Rheumatoid arthritis: a brief overview of the treatment. Medical Principles and Practice. 2018; 27(6):501-7. https://doi.org/10.1159/000493390
Louie GH, Ward MM. Changes in the rates of joint surgery among patients with Rheumatoid Arthritis in California, 1983-2007. Ann Rheum Dis 2010; 69:868-871. https://doi.org/10.1136/ard.2009.112474
Chung KC, Pushman AG. Current Concepts in the Management of the Rheumatoid Hand. J Hand Surg Am 2011; 36:736-747. https://doi.org/10.1016/j.jhsa.2011.01.019
Knut L. Radiosynovectomy in the Therapeutic Management of Arthritis. World J Nucl Med 2015; 14:10-15. https://doi.org/10.4103/1450-1147.150509
Puddu G, Cipolla M, Cerullo G, et al. Which osteotomy for a valgus knee? Int Orthop 2010; 34:239-247. https://doi.org/10.1007/s00264-009-0820-3
Khatri S, Jain DK. Autism spectrum disorder (ASD): past, present and future. CIBTech Journal of Pharmaceutical Sciences. 2018; 7(4):1-25.
Aleem A, Kabir H, Review on Swertia chirata as traditional uses to its pyhtochemistry and phrmacological activity, Journal of Drug Delivery and Therapeutics 2018; 8(5-s):73-78 https://doi.org/10.22270/jddt.v8i5-s.1957
Pajarinen J, Lin T-H, T Sato T, et al. Interaction of Materials and Biology in Total Joint Replacement- Successes, Challenges and Future Directions. J Mater Chem B Mater Biol Med 2014; 2:7094-7108. https://doi.org/10.1039/C4TB01005A
Published
How to Cite
Issue
Section
Copyright (c) 2022 Nandini Rohit, Bhupendra Thakur, Anushree Jain, Prateek Kumar Jain, Basant Khare, Yashwant Singh Jat
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
.